Lou Basenese

CIK: 0001809482

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CLIR

ClearSign Technologies Corp

Director

NDRA

ENDRA Life Sciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CLIR
ClearSign Technologies Corp
Sep 30, 2026
Award(A)
Non-Statutory Stock Options
Direct
3.8K shares-
CLIR
ClearSign Technologies Corp
Jun 30, 2026
Award(A)
Non-Statutory Stock Options
Direct
4.6K shares-
CLIR
ClearSign Technologies Corp
Mar 31, 2026
Award(A)
Non-Statutory Stock Options
Direct
3K shares-
NDRA
ENDRA Life Sciences Inc.
Jan 21, 2026
Award(A)
Direct
60.3K shares-
CLIR
ClearSign Technologies Corp
Oct 1, 2025
Award(A)
Restricted Stock Units
Direct
24.6K shares-
CLIR
ClearSign Technologies Corp
Jul 1, 2025
Award(A)
Restricted Stock Units
Direct
34.7K shares-
NDRA
ENDRA Life Sciences Inc.
Jun 11, 2025
Award(A)
Direct
5.4K shares-
CLIR
ClearSign Technologies Corp
May 22, 2025
Award(A)
Restricted Stock Units
Direct
10.9K shares-

		Type	Shares	Price		Ownership
Sep 30, 2026	CLIR ClearSign Technologies Corp	Award(A) Non-Statutory Stock Options	3,766	-	-	Direct
Jun 30, 2026	CLIR ClearSign Technologies Corp	Award(A) Non-Statutory Stock Options	4,595	-	-	Direct
Mar 31, 2026	CLIR ClearSign Technologies Corp	Award(A) Non-Statutory Stock Options	3,024	-	-	Direct
Jan 21, 2026	NDRA ENDRA Life Sciences Inc.	Award(A)	60,324	-	$0	Direct
Oct 1, 2025	CLIR ClearSign Technologies Corp	Award(A) Restricted Stock Units	24,621	-	-	Direct
Jul 1, 2025	CLIR ClearSign Technologies Corp	Award(A) Restricted Stock Units	34,722	-	-	Direct
Jun 11, 2025	NDRA ENDRA Life Sciences Inc.	Award(A)	5,384	-	-	Direct
May 22, 2025	CLIR ClearSign Technologies Corp	Award(A) Restricted Stock Units	10,923	-	-	Direct

1-8 of 8 transactions

About Basenese Lou

Basenese Lou (SEC CIK 0001809482) files insider reports with the SEC as Director of ClearSign Technologies Corp (CLIR) and Director of ENDRA Life Sciences Inc. (NDRA).

Signal8 holds 9 ownership filings by Basenese Lou (1 Form 3, 8 Form 4), filed between May 27, 2025 and Oct 2, 2026. Those filings report 8 transactions, from May 22, 2025 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Basenese Lou's filings is in TULSA, OK.

Recent filings by Basenese Lou

Sep 30, 2026: Grant or award of CLIR derivative securities (Form 4, code A).
Jun 30, 2026: Grant or award of CLIR derivative securities (Form 4, code A).
Mar 31, 2026: Grant or award of CLIR derivative securities (Form 4, code A).
Jan 21, 2026: Grant or award of NDRA shares (Form 4, code A).
Oct 1, 2025: Grant or award of CLIR derivative securities (Form 4, code A).

Other insiders filing for ClearSign Technologies Corp (CLIR)

Silva Gil Todd, Director
Saddler Larry Michael, Director
DIGIANDOMENICO ANTHONY, Director
PASQUESI JOHN M, 10% Owner
Deller Colin James, Chief Executive Officer
Hinds Brent, Chief Financial Officer

How to read Form 4 transaction codes